2024-25 Federal Budget submission: Building a healthcare system for the future
5 February 2024
The Pharmaceutical Society of Australia (PSA) is calling for investment into pharmacy and pharmacist services to improve access and equity of care as part of its 2024-25 Federal Budget Submission.
As the peak professional body for pharmacists in all areas of practice, PSA calls for the upcoming Federal Budget to support patients’ access to care and medicines through funded community pharmacist-led consultation services, an expanded National Immunisation Program Vaccinations in Pharmacy program, support for participation in multidisciplinary case conferencing, and nation-wide mental health first aid training.
Importantly, PSA also calls for the permanent introduction and funding of the Integrating Pharmacists within Aboriginal Community Controlled Health Services to Improve Chronic Disease Management, or IPAC Project, embedding vital medicines safety advocacy into Aboriginal and Torres Strait Islander primary health services. The IPAC Project is critically supported by the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Medical Services Advisory Committee (MSAC).
PSA’s recommendations signal the impact that increased scope for pharmacist services can have on the broader health system.
PSA National President Associate Professor Fei Sim FPS says that funding for pharmacist services is key to equitable and accessible care now and into the future.
“This year’s Budget is an opportunity to strengthen our healthcare system, ensuring that its fit for purpose and able to meet the current and future health needs of our population,” A/Prof Sim said.
“Pharmacists should be supported to deliver more vaccinations, to act as a key consultation and triage point, and to offer crisis support to people experiencing mental ill health.
“Pharmacists should be funded to continue our vital role in Aboriginal and Torres Strait Islander primary health services as part of the IPAC program supported by the National Aboriginal Community Controlled Health Organisation and the Medical Services Advisory Committee.
“These recommendations bolster medicine safety, and recognise pharmacists’ roles in disease management, and support access to care for all Australians.
“We can make a real difference to the patients we serve, and the health system more broadly, but our pharmacy workforce should be supported to be in these roles.
“PSA is calling for investment across five key areas that support patient access to care, bolster the quality use of medicines and medicines safety, and recognise our roles as critical to improving the disease management.
“Investing in community-based care and quality use of medicines is investing in accessible and equitable care for Australians when and where they need it,” A/Prof Sim concluded.
PSA’s full Budget Submission is available at https://www.psa.org.au/advocacy/budget-submissions/
Media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au
